Microneedling with a special ointment for vitiligo
Part of Skin clinical trials.
This trial tests whether a new combination treatment (microneedling plus a non-steroidal ointment called crisaborole) can help repigment patches of vitiligo that have been stable for a while. It is for people with non-segmental vitiligo that is not spreading.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have non-segmental vitiligo (patches on both sides of the body) that has been stable (not growing or changing) for at least some period.
- You are willing to sign a consent form to join the study.
- You do not have any signs of active disease, like new patches or the Koebner phenomenon (skin developing vitiligo where injured).
- You do not have a tendency to form keloids (raised, thickened scars).
- You are not pregnant or breastfeeding, and have no active skin infections.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two types of needle treatments (needling and microneedling) combined with light therapy to see which works better for people with vitiligo that has lasted more than a year.
This study tests whether microneedling (tiny needles that prick the skin) combined with a chemotherapy cream (5-fluorouracil) works better than a strong steroid cream for treating vitiligo patches on a small area of the body. It's for people with limited vitiligo (covering no more than 10% of their body) who have not used other vitiligo treatments.
This trial tests a new gel made from stem-cell substances (secretome) given with narrow-band UVB light therapy for stable non-segmental vitiligo. It compares two ways of applying the gel to see which works better.
This trial tests an ointment called MH004 to see if it helps repigment white patches in people with non-segmental vitiligo (the most common type). It focuses on patches on the face and body.
This trial tests whether taking small doses of steroids by mouth for a few days before and after a skin cell transplant (NCES) can reduce the white halo that sometimes forms around the treated area. It is for people with stable vitiligo on the face or trunk that hasn't responded to creams or light therapy.
This trial tests whether adding short bursts of steroid pills to a skin cell transplant procedure can improve results for people with stable vitiligo on hard-to-treat areas like elbows and knees.
Hear when a new Vitiligo trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.